Harvard Bioscience (NASDAQ:HBIO – Get Free Report) had its target price lowered by Benchmark from $5.50 to $4.50 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has a ...
Solving the source of the high-grade boulders west of the Thor epithermal deposit! ESTES PARK, CO / ACCESS Newswire / March 25, 2025 / Taranis Resources Inc. ("Taranis" or the "Company" ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback